OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
Publish Date Publish Date | Title Title | Period End Date Period End Date | Status Status |
---|---|---|---|
08/16/2023 | Notification of Late Filing | 06/30/2023 | A |
07/19/2023 | Supplemental Information - Material Definitive Agreement | 07/19/2023 | A |
05/10/2023 | Attorney Letter with Respect to Current Information - Current Information - Covering annual reports ending 12/31/2021 and 12/31/2022 (2nd amendment to correct date references) | 12/31/2022 | A |
05/08/2023 | Attorney Letter with Respect to Current Information - Covering annual reports ending 12/31/2021 and 12/31/2022 (amended to correct date reference) | 12/31/2022 | A |
05/02/2023 | Quarterly Report - March 31, 2023 | 03/31/2023 | A |
05/01/2023 | Attorney Letter with Respect to Current Information - Covering annual reports ending 12/31/2021 and 12/31/2022. | 12/31/2022 | A |
04/30/2023 | Annual Report - December 31, 2022 | 12/31/2022 | A |
04/30/2023 | Quarterly Report - September 30, 2022 | 09/30/2022 | A |
04/30/2023 | Quarterly Report - June 30, 2022 | 06/30/2022 | A |
04/30/2023 | Quarterly Report - March 31, 2022 | 03/31/2022 | A |
No insider disclosure available for CFGX.
No SEC transactions available for CFGX.